J&J to spin off consumer products and focus on pharmaceuticals
Johnson & Johnson (JNJ.N) plans to spin off its consumer health division that sells Listerine and Baby Powder to focus on pharmaceuticals and medical devices...
Continue ReadingGUBBA PHARMA IN E NEWS
UK becomes first country to approve Merck’s anti-Covid pill molnupiravir
Britain approved the use of Merck’s antiviral pill to treat patients suffering from mild to moderate Covid-19, the Medicines and Healthcare products Regulatory Agency (MHRA)...
Continue ReadingSun Pharma might finally have a prescription for the specialty dream
Sun Pharmaceutical Industries is increasingly showing signs that it has left behind the stuttering start to its journey to become a The drugmaker reported 6...
Continue ReadingMolnupiravir and Paxlovid: Two new oral drugs and the treatment of Covid-19
The UK drug regulator announced that it has approved the first oral antiviral for treatment of Covid-19. The drug, molnupiravir, has been developed by Merck...
Continue ReadingCadila Healthcare gets Central govt order to supply 10 mn doses of ZyCoV-D
Cadila Healthcare (Zydus Cadila) on Monday said it has received an order to supply 10 million doses of ZyCoV-D, the world’s first Plasmid DNA vaccine,...
Continue ReadingCovid-19: Monoclonal antibody therapy ‘fully prevents’ severe disease, death: AIG Hospitals Study
Monoclonal therapy reduces severe disease and death in high-risk individuals infected with the Delta Variant of Covid-19 by 100 per cent, according to findings of...
Continue ReadingAI and ML hold answers for Indian pharma’s logistics challenges
Rahul Vishwakarma, Co-founder and CEO, Mate Labs, asserts that deploying Artificial Intelligence (AI) and Machine Learning (ML) at scale can make the pharma industry more...
Continue ReadingIndian cos asked to bid for molnupiravir deal
Unitaid, a global health initiative that works with partners to bring about innovations to prevent, diagnose, and treat major diseases in low- and middle-income countries,...
Continue Reading
Govt to finalise OTC drug policy soon
India’s over-the-counter drug regulation, which has been in the works for more than four years, is likely to be out soon as the government is...
Continue Reading